Display options
Share it on

Ned Tijdschr Geneeskd. 2021 Apr 28;165.

[Temporary suspension of AstraZeneca's vaccine; a reconstruction].

Nederlands tijdschrift voor geneeskunde

[Article in Dutch]
D P M S M Maas, C Kramers, H J C A Smit, S Middeldorp, I Helsloot

Affiliations

  1. Radboudumc, afd. Interne Geneeskunde, Nijmegen.
  2. Contact: D.P.M.S.M. Maas ([email protected]).
  3. Radboudumc, afd. Interne Geneeskunde, Nijmegen(tevens: afd. Farmacologie-Toxicologie en Canisius Wilhelmina Ziekenhuis, afd. Klinische Farmacie, Nijmegen).
  4. Canisius Wilhelmina Ziekenhuis, afd. Klinische Farmacie, Nijmegen.
  5. Radboud Universiteit, faculteit Bestuurskunde, Nijmegen.

PMID: 33914428

Abstract

In the middle of the worldwide COVID-19 crisis, the whole of Europe was alarmed about a possible side effect of the AstraZeneca vaccine against COVID-19. Consequently, the use of this AstraZeneca vaccine was temporarily suspended in many European nations including the Netherlands. In this article, we chronologically describe the decisions that were made about the use of this vaccine in the Netherlands and we discuss the risk-benefit ratios of these actions as well as possible non-medical reasons that may explain why these actions were taken.

Substances

MeSH terms

Publication Types